Approvals/CIMA-AEMPS/RONAPREVE 300 MG + 300 MG SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN

Approved

STANDARD

RONAPREVE 300 MG + 300 MG SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN

Roche Registration Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: e82b4b1ae3bc5f3a
Drug Cima Aemps Name: RONAPREVE 300 MG + 300 MG SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Register Number: 1211601001
Holder Company Name: Roche Registration Gmbh
Marketing Company Name: Roche Farma S.A.
Holder Company Detail Path: /organization/roche-registration-gmbh
Authorization Date: 2021-11-18
Dosage Form: SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Dose: 120 mg/ml
Route Of Administration: VÍA INTRAVENOSA, VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Roche Registration Gmbh
Company Detail Path: /organization/roche-registration-gmbh

CASIRIVIMAB

300 mg

IMDEVIMAB

300 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 18, 2021

Approval ID

e82b4b1ae3bc5f3a

Type

Standard